Ledgewood Wealth Advisors, LLC Arbutus Biopharma Corp Transaction History
Ledgewood Wealth Advisors, LLC
- $155 Billion
- Q1 2025
A detailed history of Ledgewood Wealth Advisors, LLC transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Ledgewood Wealth Advisors, LLC holds 278,436 shares of ABUS stock, worth $988,447. This represents 0.63% of its overall portfolio holdings.
Number of Shares
278,436
Previous 278,436
-0.0%
Holding current value
$988,447
Previous $910 Million
6.73%
% of portfolio
0.63%
Previous 0.59%
Shares
1 transactions
Others Institutions Holding ABUS
# of Institutions
169Shares Held
101MCall Options Held
649KPut Options Held
666K-
Morgan Stanley New York, NY22.6MShares$80.2 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.2MShares$47 Million22.74% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.98MShares$31.9 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.74MShares$31 Million4.68% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $532M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...